Big angiotensin-25: A novel glycosylated angiotensin-related peptide isolated from human urine

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 757-762

  Nagata, Sayaka ^a   Hatakeyama, Kinta ^a   Asami, Maki ^a   Tokashiki, Mariko ^a   Hibino, Hajime ^b   Nishiuchi, Yuji ^b,c   Kuwasako, Kenji ^d   Kato, Johji ^d   Asada, Yujiro ^a   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Peptide Institute Inc   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Angiotensinogen; Bigangiotensin 25; Glycosyl chain; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; BIG ANGIOTENSIN 25; CHYMASE; GLYCOSYLATED PROTEIN; RENIN; UNCLASSIFIED DRUG;

ARTICLE; CATECHOLAMINE RELEASE; ENZYME KINETICS; GEL FILTRATION; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NORMAL HUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOIMMUNOASSAY; SEQUENCE ANALYSIS; TROPHOBLAST; URINE;

ANGIOTENSINOGEN; BIGANGIOTENSIN-25; GLYCOSYL CHAIN; RENIN-ANGIOTENSIN SYSTEM;

AMINO ACID SEQUENCE; ANGIOTENSIN II; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; TISSUE DISTRIBUTION;

EID: 84888845216     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.124     Document Type: Article

References (27)

1. Oparil S., Haber E. The renin-angiotensin system (first of two parts). N. Engl. J. Med. 1974, 291:389-401.
2. Dzau V.J., Burt D.W., Pratt R.E. Molecular biology of the renin-angiotensin system. Am. J. Physiol. 1988, 255:F563-573.
3. Miyazaki M., Takai S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J. Pharmacol. Sci. 2006, 100:391-397.
4. Campbell D.J. Circulating and tissue angiotensin systems. J. Clin. Invest. 1987, 79:1-6.
5. Nossaman B.D., Feng C.J., Kaye A.D., Kadowitz P.J. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat. Am. J. Physiol. 1995, 268:L302-308.
6. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 2002, 109:1417-1427.
7. Block C.H., Santos R.A., Brosnihan K.B., Ferrario C.M. Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides 1988, 9:1395-1401.
8. Campbell W.B., Brooks S.N., Pettinger W.A. Angiotensin II- and angiotensin 3-induced aldosterone release vivo in the rat. Science 1974, 184:994-996.
9. Nagata S., Kato J., Sasaki K., Minamino N., Eto T., Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem. Biophys. Res. Commun. 2006, 350:1026-1031.
10. Nagata S., Kato J., Kuwasako K., Kitamura K. Plasma and tissue levels of proangiotensin-12 and components of the renin-angiotensin system (RAS) following low- or high-salt feeding in rats. Peptides 2010, 31:889-892.
11. Nagata S., Kato J., Kuwasako K., Asami M., Kitamura K. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system. Hypertens. Res. 2012, 35:234-238.
12. Kitamura K., Ichiki Y., Tanaka M., Kawamoto M., Emura J., Sakakibara S., Kangawa K., Matsuo H., Eto T. Immunoreactive adrenomedullin in human plasma. FEBS Lett. 1994, 341:288-290.
13. Nakagawa H., Kawamura Y., Kato K., Shimada I., Arata Y., Takahashi N. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal. Biochem. 1995, 226:130-138.
14. Yagi H., Takahashi N., Yamaguchi Y., Kimura N., Uchimura K., Kannagi R., Kato K. Development of structural analysis of sulfated N-glycans by multidimensional high performance liquid chromatography mapping methods. Glycobiology 2005, 15:1051-1060.
15. Zhou A., Carrell R.W., Murphy M.P., Wei Z., Yan Y., Stanley P.L., Stein P.E., Broughton Pipkin F., Read R.J. A redox switch in angiotensinogen modulates angiotensin release. Nature 2010, 468:108-111.
16. Nakagawa H., Kawamura Y., Kato K., Shimada I., Arata Y., Takahashi N. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal. Biochem. 1995, 226:130-138.
17. Gimenez-Roqueplo A.P., Celerier J., Lucarelli G., Corvol P., Jeunemaitre X. Role of N-glycosylation in human angiotensinogen. J. Biol. Chem. 1998, 273:21232-21238.
18. Inui Y., Orihashi T., Nakagawa T., Ebihara A., Suzuki F., Nakamura Y. Effects of glycosylation of the residue at position 14 in ovine angiotensinogen on the human renin reaction. Biosci., Biotechnol., Biochem. 1998, 62:1612-1614.
19. Streatfeild-James R.M., Williamson D., Pike R.N., Tewksbury D., Carrell R.W., Coughlin P.B. Angiotensinogen cleavage by renin: importance of a structurally constrained N-terminus. FEBS Lett. 1998, 436:267-270.
20. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 1990, 265:22348-22357.
21. Luther J.M., Brown N.J. The renin-angiotensin-aldosterone system and glucose homeostasis. Trends Pharmacol. Sci. 2011, 32:734-739.
22. Peters J. Local renin-angiotensin systems in the adrenal gland. Peptides 2012, 34:427-432.
23. Liebau M.C., Lang D., Bohm J., Endlich N., Bek M.J., Witherden I., Mathieson P.W., Saleem M.A., Pavenstadt H., Fischer K.G. Functional expression of the renin-angiotensin system in human podocytes. Am. J. Physiol. Renal Physiol. 2006, 290:F710-719.
24. Dai H.Y., Zheng M., Tang R.N., Ma K.L., Ni J., Liu B.C. Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats. Chin. Med. J. 2012, 125:888-893.
25. Fukuda A., Wickman L.T., Venkatareddy M.P., Sato Y., Chowdhury M.A., Wang S.Q., Shedden K.A., Dysko R.C., Wiggins J.E., Wiggins R.C. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int. 2012, 81:40-55.
26. Takai S., Jin D., Miyazaki M. Multiple mechanisms for the action of chymase inhibitors. J. Pharmacol. Sci. 2012, 118:311-316.
27. Takai S., Sakaguchi M., Jin D., Yamada M., Kirimura K., Miyazaki M. Different angiotensin II-forming pathways in human and rat vascular tissues. Clin. Chim. Acta 2001, 305:191-195.